Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mikati-Najjar-Sahli syndrome is characterized by microcephaly, hypergonadotropic hypogonadism, short stature and facial dysmorphism (a narrow forehead, hypertrophy and fusion of the eyebrows, micrognathia and pinnae abnormalities).
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Mikati-Najjar-Sahli syndrome.
200 publications have been identified in PubMed for Mikati-Najjar-Sahli syndrome. Kisho has analyzed 81 by research type. Research spans Review / Meta-Analysis (69%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 56 | 69% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Mikati-Najjar-Sahli syndrome
Laboratory research
15 |
19% |
Disease patterns and progression | 6 | 7% |
Patient case studies | 3 | 4% |
Clinical study results | 1 | 1% |
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Gencer NS (2025). [PMID: 41291504](https://pubmed.ncbi.nlm.nih.gov/41291504/). *BMC Geriatr*. [Epidemiology / Natural History]
Borojeni S (2025). [PMID: 40546148](https://pubmed.ncbi.nlm.nih.gov/40546148/). *Rev Prat*. [Review / Meta-Analysis]
Pena C (2025). [PMID: 40146047](https://pubmed.ncbi.nlm.nih.gov/40146047/). *Minerva Med*. [Review / Meta-Analysis]
Walther LE (2025). [PMID: 40192781](https://pubmed.ncbi.nlm.nih.gov/40192781/). *HNO*. [Review / Meta-Analysis]
Yacoub MR (2025). [PMID: 40747632](https://pubmed.ncbi.nlm.nih.gov/40747632/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Cornejo-Sanchez DM (2025). [PMID: 40055553](https://pubmed.ncbi.nlm.nih.gov/40055553/). *Eur J Hum Genet*. [Basic Science / Preclinical]
Koriath CAM (2025). [PMID: 39443079](https://pubmed.ncbi.nlm.nih.gov/39443079/). *J Neurol Neurosurg Psychiatry*. [Review / Meta-Analysis]
McCarthy FH (2025). [PMID: 40268352](https://pubmed.ncbi.nlm.nih.gov/40268352/). *Cardiol Clin*. [Review / Meta-Analysis]